A new study published in JAMA Network Open explores how cannabis legalization, both medical and recreational, is affecting the prescription of mental health medications in the U.S. The findings reveal a complex relationship, with cannabis laws leading to both decreased benzodiazepine prescriptions and increased use of antidepressants and antipsychotics. This underscores the need for further research into the broader impact of cannabis legalization on mental health treatment.